Jun Ando

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

Vitamin B6 deficiency as a cause of erythropoietin-stimulating agent-resistant anemia in hemodialysis patients: A report of two cases.

Vitamin B6 deficiency as a cause of erythropoietin-stimulating agent-resistant anemia in hemodialysis patients: A report of two cases.

Journal: Internal medicine (Tokyo, Japan)

Published: July 12, 2026

Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective study.

Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective study.

Journal: Annals of hematology

Published: May 10, 2026

TFH phenotype and response to tucidinostat in relapsed/refractory PTCL: analysis of patients from a phase IIb trial.

TFH phenotype and response to tucidinostat in relapsed/refractory PTCL: analysis of patients from a phase IIb trial.

Journal: International journal of hematology

Published: March 18, 2026

Dual-antigen recognition iPSC-derived CAR-T cells for B-cell malignancies: establishment of a COVID-19 vaccine synergy strategy.

Dual-antigen recognition iPSC-derived CAR-T cells for B-cell malignancies: establishment of a COVID-19 vaccine synergy strategy.

Journal: Frontiers in cell and developmental biology

Published: December 20, 2025

Persistent COVID-19 in Patients With Hematological Malignancies: A Focused Review in the Omicron Era.

Persistent COVID-19 in Patients With Hematological Malignancies: A Focused Review in the Omicron Era.

Journal: Clinical lymphoma, myeloma & leukemia

Published: October 06, 2025

Digital SERS bioanalysis of single-enzyme biomarkers.

Digital SERS bioanalysis of single-enzyme biomarkers.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 02, 2025

Real-world outcomes of venetoclax and azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia (VENUS study).

Real-world outcomes of venetoclax and azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia (VENUS study).

Journal: International journal of hematology

Published: June 15, 2025

Early Epcoritamab Administration Revives CAR-T Cells in Relapsed/Refractory B-Cell Lymphomas.

Early Epcoritamab Administration Revives CAR-T Cells in Relapsed/Refractory B-Cell Lymphomas.

Journal: EJHaem

Published: May 12, 2025

Application of Convolutional Neural Network Image Analysis and Machine Learning to Basic Blood Tests for Intelligent Diagnostic Assistance.

Application of Convolutional Neural Network Image Analysis and Machine Learning to Basic Blood Tests for Intelligent Diagnostic Assistance.

Journal: International journal of laboratory hematology

Published: March 10, 2025

Clinical outcomes of Japanese patients treated with out-of-specification tisagenlecleucel in a phase 3b trial.

Clinical outcomes of Japanese patients treated with out-of-specification tisagenlecleucel in a phase 3b trial.

Journal: Cytotherapy

Published: January 08, 2025

TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy.

TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy.

Journal: Annals of hematology

Published: December 21, 2024

Assessment and management of pregnancy in patients with myeloproliferative neoplasms: insights from a single-institution study of 29 neonates.

Assessment and management of pregnancy in patients with myeloproliferative neoplasms: insights from a single-institution study of 29 neonates.

Journal: International journal of hematology

Published: October 22, 2024

Showing 1-12 of 99

Last Updated: 09/26/2026